You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rhGAD65 (Recombinant Human GAD with molecular mass 65,000)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1 Trial in Linköping (GAD-alum (Diamyd) 40 µg/mL)

Recruiting
  • Diabetes Mellitus, Type 1
  • GAD-alum (Diamyd) 40 μg/mL
  • Linköping, Sweden
    Kliniska Forskningsenheten (Hudmottagningen), Universitetssjukhu
Aug 17, 2022

Type 1 Diabetes Trial in Canada, United States (GAD-Alum, GAD-Alum and Aluminum hydroxide, Aluminum hydroxide)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Los Angeles, California
  • +14 more
Apr 27, 2020

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Diabetes, Type 1 Trial in Sweden (GAD-Alum, Vitamin D, Etanercept)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Helsingborg, Sweden
  • +7 more
Mar 26, 2021

Severe Hemophilia A Trial in China (FRSW117)

Not yet recruiting
  • Severe Hemophilia A
  • Beijing, China
  • +27 more
Nov 16, 2023

Type I Diabetes Trial in Birmingham (Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active

Completed
  • Type I Diabetes
  • Placebo GABA and Placebo GAD-alum
  • +2 more
  • Birmingham, Alabama
    Children's of Alabama
May 2, 2022

Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
Jan 17, 2023

Diabetes, Type 1 Trial in Linköping (GAD-Alum, Vitamin D)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Linköping, Sweden
    Linköping University
Apr 15, 2020

Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)

Not yet recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Recombinant Human Adenovirus Type 5
  • HAIC of FOLFOX
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Mar 16, 2022

Tooth Extraction, Immediate Implant Placement Trial in Iowa City (Xenogeneic Volume-Stable Collagen (VCMX) graft with growth

Not yet recruiting
  • Tooth Extraction
  • Immediate Implant Placement
  • Xenogeneic Volume-Stable Collagen (VCMX) graft with growth factor-BB
  • Iowa City, Iowa
    University of Iowa College of Dentistry and Dental Clinics
Sep 8, 2023

Gulf War Syndrome, Adult Growth Hormone Deficiency Trial in Houston, Seattle (Recombinant human growth hormone, Placebo)

Not yet recruiting
  • Gulf War Syndrome
  • Adult Growth Hormone Deficiency
  • Recombinant human growth hormone
  • Placebo
  • Houston, Texas
  • +1 more
Apr 26, 2022

Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

Enrolling by invitation
  • Malignant Melanomas
  • Recombinant Human Adenovirus Type 5 Injection
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023

SARS-CoV-2 Infection Trial in Mexico (AVX-COVID/12, ChAdOx-1-S[recombinant])

Recruiting
  • SARS-CoV-2 Infection
  • AVX-COVID/12
  • ChAdOx-1-S[recombinant]
  • Mexico City, Cdmx, Mexico
  • +13 more
Feb 3, 2023

Coronavirus Infection, COVID Trial in Adelaide (COVID19 vaccine, Saline)

Completed
  • Coronavirus Infection
  • COVID
  • COVID19 vaccine
  • Saline
  • Adelaide, South Australia, Australia
    PARC,
Feb 12, 2022

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Radiotherapy
  • +4 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023

Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Transarterial Chemoembolization (TACE))

Not yet recruiting
  • Hepatocellular Carcinoma
  • Sintilimab
  • Transarterial Chemoembolization (TACE)
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 17, 2023

Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

Not yet recruiting
  • Advanced Mucosal Melanoma
  • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
  • (no location specified)
Sep 15, 2023

Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

Not yet recruiting
  • Hepatic Ascites
  • Recombinant Human Serum Albumin
  • Human serum albumin
  • Guangdong, Shenzhen, China
    Shenzhen Protgen Ltd
May 5, 2023

Long-lasting Adaptation to Endurance and Speed-power Training on

Active, not recruiting
  • Healthy Athletes Aged 18-35 Years
  • Sprint training
  • +2 more
  • Poznań, Wielkoolska, Poland
    Poznan University of Physical Education
Jan 5, 2023

Massive Pulmonary Embolism Trial in Russian Federation (Recombinant nonimmunogenic staphylokinase, Alteplase)

Recruiting
  • Massive Pulmonary Embolism
  • Recombinant nonimmunogenic staphylokinase
  • Alteplase
  • Barnaul, Russian Federation
  • +16 more
Feb 7, 2022

Clinical Markers of Panic and Generalized Anxiety Disorder

Completed
  • Generalized Anxiety Disorder
  • +2 more
  • Structured Clinical Interview for DSM-5
  • Monza, MB, Italy
    University of Milano Bicocca - Fondazione IRCCS San Gerardo dei
Oct 4, 2023

Leukemia, Lymphocytic, Chronic Trial run by the NCI (rhIL-15, Obinutuzumab)

Terminated
Has Results
  • Leukemia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 11, 2022

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
Has Results
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Natural Blood and Blood Product Toxicity Trial in Dhaka (Erythropoietin alpha)

Completed
  • Natural Blood and Blood Product Toxicity
  • Erythropoietin alpha
  • Dhaka, Bangladesh
  • +1 more
Oct 18, 2022

Assessment of Recombinant HAT-RDT Specificity

Recruiting
  • Human African Trypanosomiasis
    • Kinshasa, Congo, The Democratic Republic of the
      Programme National de Lutte contre la Trypanosomiase Humaine Afr
    Nov 24, 2022